July 2024
Core topics in this month’s edition include:
- Kisunla (donanemab-azbt)– new drug approval
- Corlanor (ivabradine) – first time generic
- Palforzia (peanut [Arachis hypogaea] allergen powder-dnfp) – expanded indication
- Zunveyl (benzgalantamine) – new drug approval